Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is pronounced tir-ZEP-a-tide. Say it in four syllables: tir (rhymes with "her"), ZEP (the stressed beat, like "zeppelin"), a (a soft, quick "uh"), then tide (like the sea). Most people stumble on where the emphasis sits, not on the sounds themselves. It is a prescription-only medicine, sold in the UK under the brand name Mounjaro, and a prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Break it down once and it sticks. The four-syllable split is: tir / ZEP / a / tide. The first syllable rhymes with "her" or "sir", a short, closed sound. The second syllable, ZEP, takes the stress; speak it with a little extra weight and the rest of the word falls into place. The third is a near-silent "uh". The fourth, "tide", is identical to the word for the ocean's rise and fall.
A rough phonetic guide: teer-ZEP-uh-tide is also heard in British English, with a slightly longer first vowel. Both are correct; regional accent does the rest. The thing to avoid is landing the stress on the first syllable, TIR-ze-pa-tide sounds wrong to clinicians and pharmacists who use the name daily. Get ZEP right and you are almost there.
If you want to hear the word spoken, the NHS medicines page for tirzepatide gives a reliable starting point for how the medicine is discussed in a UK clinical context, and our own tirzepatide overview covers the medicine in plain English.
Mounjaro is the UK trade name Eli Lilly chose for tirzepatide. Pronounce it mown-JAR-oh: three syllables, stress on the second. "Mown" as in freshly cut grass. "JAR" with the stress. "Oh" to finish. It is a distinctive name (memorable by design) and the emphasis on the middle syllable is consistent in Lilly's own communications and across NHS and MHRA documentation.
A common slip is spreading it to four syllables (moun-JA-a-ro) or stressing the first (MOWN-ja-ro). Neither is standard. If you have been saying it slightly differently, you are in good company, our prescribers hear variations regularly. More on what Mounjaro is and how it works if you want the clinical picture alongside the correct name.
The distinction between the brand name and the generic matters in practice: a pharmacy, GP or prescriber may use either, and knowing both means you can follow a clinical conversation confidently.
Pharmaceutical generic names are not random. The World Health Organization's International Nonproprietary Name (INN) system assigns stems to drug classes so that the name itself signals the medicine's family. The "-tide" ending places tirzepatide alongside other peptide-based drugs. The "tirze-" prefix is specific to this compound, coined by Eli Lilly during development. The full INN, tirzepatide, became the globally recognised non-brand name after WHO approval.
This matters beyond trivia. Tirzepatide is a once-weekly subcutaneous injection that activates two gut-hormone receptors (GIP and GLP-1) involved in appetite regulation and blood-sugar control. It is the only dual-agonist medicine of its kind currently licensed in the UK for weight management. Understanding the name helps you recognise it across prescription paperwork, patient information leaflets and clinical letters, all of which may use the generic name rather than the brand.
The UK licence covers weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. A prescriber reviews the full clinical picture; meeting the number alone does not determine suitability.
Practically, no. A pharmacist or prescriber will understand you from context, particularly if you also mention Mounjaro or have your prescription in hand. That said, getting the pronunciation right does make conversations run more smoothly, and it can feel reassuring to walk into a consultation already familiar with the name of the medicine you want to discuss.
One thing our clinical team notices: patients sometimes arrive having rehearsed the brand name but not the generic, or vice versa. Knowing both (Mounjaro (mown-JAR-oh) and tirzepatide (tir-ZEP-a-tide)) means nothing in your appointment catches you off guard. For a full pronunciation walkthrough with audio context, our page on pronouncing tirzepatide in English goes into further detail.
If you are at the stage of thinking about whether treatment could be right for you, the weight-loss treatment overview sets out how the medicine fits into a broader clinical plan. The cost side of private treatment is covered on the Mounjaro UK pricing page, which explains how list prices have shifted and what a legitimate private prescription includes. These are prescription-only medicines; the guide on saying tirzepatide and related pages are here to inform, not to substitute for a clinical assessment. When you are ready to take that step, a real prescriber (not an automated system) reviews your consultation before anything is dispensed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.